Latest News
News
Topline results of Phase 2 Long Covid trial do not show evidence of superior efficacy of BC 007 over placebo arm
News
Berlin Cures Welcomes Renowned Immunologist Professor Danny Altmann to its Advisory Board
News
Berlin Cures announces changes to Board of Directors to further propel the development of BC 007
News
Recruitment completed: Berlin Cures achieves key milestone in BC 007 Phase II Trial for treatment of Long COVID
News
Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board
News
Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
News
Berlin Cures advances fight against Long COVID on a pan-European level
News
Berlin Cures takes next step in battle against Long COVID. Collaboration with Uniklinikum Erlangen as 5th German research center.
News
Berlin Cures starts Long COVID Phase II Trial – first patients admitted. Dr. Axel Mescheder appointed Chief Medical Officer.
News
Berlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth.
News
Heart Failure Treatment from Berlin Cures Shows Promise in Phase I Study.
News
BC 007 was successfully used for the treatment of a Long Covid Patient.
News
Functional autoantibodies against G protein-coupled receptors in patients with persistent Long-COVID-19 symptoms.
News
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007.
News
The DNA-Based Drug BC 007 neutralizes agonistically acting autoantibodies directed against G protein-coupled receptors.
News
Berlin Cures’ Steering Committee is Assembled to Facilitate the Design and Implementation of Phase II Study of BC 007.
News
Characterization of Aptamer BC 007 Substance and Product Using Circular Dichroism and Nuclear Magnetic Resonance Spectroscopy.
News
Berlin Cures Announces Formation of Scientific Advisory Board.
Media Coverage
The University Hospital in Erlangen believes it may have found a drug against Long Covid.
Doctors have succeeded in doing something that has never been done before: four Long Covid patients could be cured by administering a heart drug that has not yet been approved.
Has there been a breakthrough in the treatment of Long Covid?
Successful therapy trials in Erlangen raise great hope for the treatment of Long Covid.
Tagesschau reports on the treatment of long term effects of Corona.
A new drug raises hope for Long Covid.
Interesting interview with neurologist Michael Stingl on the treatment of Long Covid.
Long Covid patients are on the road to recovery thanks to the drug BC 007.
A Long Covid patient is cured thanks to the drug BC 007 from the start-up Berlin Cures.
Where to
meet us
meet us
Demystifying Long COVID International Conference | 21-22 November 2024 | Barcelona, Spain
A Long COVID conference for healthcare professionals, investigators, policymakers, and community representatives.
BIO-Europe | 04-06 November 2024 | Stockholm, Sweden
